Loading market dashboard
SS Innovations International, Inc.
SSIIHealthcareNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Fort Lauderdale, FL, June 4, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that a robot-assisted heart procedure was successfully performed with the SSi Mantra surgical robotic system (the “SSi Mantra”) across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India, making it the world's longest-distance robotic telesurgery ever conducted.
FORT LAUDERDALE, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that a robot-assisted heart procedure was successfully performed with the SSi Mantra surgical robotic system (the “SSi Mantra”) across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India, making it the world's longest-distance robotic telesurgery ever conducted.
Board Appointment Enhances UberDoc's Strategic Positioning in the Rapidly Growing Direct-Pay Healthcare Market Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE: APPT) (FSE: 4KL0) is pleased to announce the appointment of John Dvor to its Board of Directors as the company continues to scale its nationwide direct-pay specialty care marketplace and expand strategic partnerships in advanced medical services and technologies. John Dvor brings deep experience and extensive relationships across medical innovation, healthcare technology, advanced therapeutics, cancer care, longevity medicine, and pharmacogenetics – particularly within the rapidly growing direct-pay healthcare sector.
Record quarterly revenue driven by strong growth in SSi Mantra installations and procedures Fort Lauderdale, FL, May 13, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
FORT LAUDERDALE, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three months ended March 31, 2026.
Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console FORT LAUDERDALE, Fla., May 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console
Fort Lauderdale, FL, May 5, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that more than 10,500 cumulative surgeries have been successfully performed with the Company's SSi Mantra surgical robotic system (the “SSi Mantra”).
FORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that more than 10,500 cumulative surgeries have been successfully performed with the Company's SSi Mantra surgical robotic system (the “SSi Mantra”).
$AERA $BCBC $ACON $SKYX $AUUD $SSII $BIEI $ATCH PRISM MarketViev About PRISM MediaWire PRISM MediaWire is a New York City–based press release distribution company specializing in capital markets communications for publicly traded companies.
Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion Fort Lauderdale, FL, April 23, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
FORT LAUDERDALE, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has unveiled its vision for several cutting-edge surgical robotic technologies at the Global Multi-Specialty Robotic Surgery Conference (“SMRSC 2026”), which the Company recently hosted in New Delhi, India.
Conference to Unite Global Leaders at the Forefront of Surgical Robotic Innovation FORT LAUDERDALE, Fla., April 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
FORT LAUDERDALE, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company is hosting the Global Multi-Specialty Robotic Surgery Conference (“SMRSC 2026”) in New Delhi, India from April 9-11, 2026.
SS Innovations International (NASDAQ: SSII - Get Free Report) and Aterian (NASDAQ: ATER - Get Free Report) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Analyst Ratings This is a summary
SS Innovations achieved record Q4 revenue of $14.5m, capping a fiscal year with 106% top-line growth driven by increased sales volume. Sequential revenue growth in Q4 was partially offset by a decline in gross margin, highlighting some profitability challenges amid rapid expansion. SSII's investment thesis includes a significant upside on potential US approval of the SSi Mantra, which could materially impact future growth and valuation.
Fort Lauderdale, FL, March 30, 2026 – PRISM MediaWire (Press Release Service – SS Innovations International, Inc.
FORT LAUDERDALE, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has received regulatory approval for the SSi Mantra surgical robotic system (the “SSi Mantra”), for multiple indications in Colombia, Oman, Sri Lanka and Kenya.
Company surpasses milestone of 150 cumulative telesurgeries successfully performed with the SSi Mantra Fort Lauderdale, FL, March 18, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
FORT LAUDERDALE, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines.
Strong growth in SSi Mantra installations, procedures and revenues Fort Lauderdale, FL, March 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
FORT LAUDERDALE, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and twelve months ended December 31, 2025.
Financing led by Certain of the Company's Directors and Executive Officers Fort Lauderdale, FL, March 9, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
FORT LAUDERDALE, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that on March 6, 2026, the Company completed a private placement of its common stock (the “Private Placement”) which generated approximately $18.6 million in gross proceeds, before deducting offering expenses.
